Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer (Q45850052)

16 December 2017

title

Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer (English)

1 reference

16 December 2017

0 references

1 reference

1 reference

4

1 reference

16 December 2017

Rune Smaaland

5

object named as

Rune Smaaland

1 reference

16 December 2017

Pasquale F Innominato

1

1 reference

16 December 2017

Sylvie Giacchetti

2

1 reference

16 December 2017

Thierry Moreau

3

1 reference

16 December 2017

Christian Focan

6

1 reference

16 December 2017

Carlo Garufi

7

1 reference

16 December 2017

Stefano Iacobelli

8

1 reference

16 December 2017

Marco Tampellini

9

1 reference

16 December 2017

Salvatore Tumolo

10

1 reference

16 December 2017

Carlos Carvalho

11

1 reference

16 December 2017

Abdoulaye Karaboué

12

1 reference

16 December 2017

Antoine Poncet

13

1 reference

16 December 2017

David Spiegel

14

1 reference

16 December 2017

Francis Lévi

15

1 reference

16 December 2017

International Association for Research on Time in Biology and Chronotherapy (ARTBC) Chronotherapy Group

16

1 reference

16 December 2017

language of work or name

English

0 references

publication date

30 April 2013

1 reference

16 December 2017

published in

Cancer

1 reference

16 December 2017

volume

119

1 reference

16 December 2017

issue

14

1 reference

16 December 2017

page(s)

2564-2573

1 reference

16 December 2017

Dosing strategies for anticancer drugs: the good, the bad and body-surface area

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Circadian timing in cancer treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

The mammalian circadian timing system: organization and coordination of central and peripheral clocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Circadian rhythms: mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Chronotherapy and the molecular clock: Clinical implications in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: implications for innovative therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Jet lag: trends and coping strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

The rhythm of rest and excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Definition and classification of cancer cachexia: an international consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Translational approaches to treatment-induced symptoms in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Cancer chronotherapy: principles, applications, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Rhythms in human gastrointestinal mucosa and skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Rhythms in human bone marrow and blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Methodological challenges when using actigraphy in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28072

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.28072

1 reference

16 December 2017

PubMed ID

23633399

1 reference

16 December 2017